ZA901854B - Pharmaceutical product for the treatment of immunoregulatory disorders - Google Patents

Pharmaceutical product for the treatment of immunoregulatory disorders

Info

Publication number
ZA901854B
ZA901854B ZA901854A ZA901854A ZA901854B ZA 901854 B ZA901854 B ZA 901854B ZA 901854 A ZA901854 A ZA 901854A ZA 901854 A ZA901854 A ZA 901854A ZA 901854 B ZA901854 B ZA 901854B
Authority
ZA
South Africa
Prior art keywords
treatment
pharmaceutical product
immunoregulatory disorders
immunoregulatory
disorders
Prior art date
Application number
ZA901854A
Other languages
English (en)
Inventor
Margreet Jonker
Jonker Margreet
Petrus Hendrikus Van Der Meide
Hendrikus Van Der Meide Petrus
Original Assignee
Jonker Margreet
Hendrikus Van Der Meide Petrus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jonker Margreet, Hendrikus Van Der Meide Petrus filed Critical Jonker Margreet
Publication of ZA901854B publication Critical patent/ZA901854B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA901854A 1989-03-09 1990-03-09 Pharmaceutical product for the treatment of immunoregulatory disorders ZA901854B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898905400A GB8905400D0 (en) 1989-03-09 1989-03-09 Medicaments

Publications (1)

Publication Number Publication Date
ZA901854B true ZA901854B (en) 1991-11-27

Family

ID=10653019

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA901854A ZA901854B (en) 1989-03-09 1990-03-09 Pharmaceutical product for the treatment of immunoregulatory disorders

Country Status (8)

Country Link
EP (1) EP0387095A1 (fr)
JP (1) JPH04505010A (fr)
KR (1) KR920701466A (fr)
AU (1) AU5263490A (fr)
CA (1) CA2011893A1 (fr)
GB (2) GB8905400D0 (fr)
WO (1) WO1990010707A1 (fr)
ZA (1) ZA901854B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
WO1992003145A1 (fr) * 1990-08-27 1992-03-05 Peptide Technology Ltd. Procede de traitement des infections virales
AU654501B2 (en) * 1990-08-27 1994-11-10 Peptide Technology Ltd. Method of treating viral infection
US6277969B1 (en) 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US7192584B2 (en) 1991-03-18 2007-03-20 Centocor, Inc. Methods of treating psoriasis with anti-TNF antibodies
FR2677654B1 (fr) * 1991-06-17 1995-11-17 Pasteur Merieux Serums Vacc Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv.
ATE172880T1 (de) * 1992-08-28 1998-11-15 Bayer Ag Verwendung von monoklonalen anti-tnf-antikörpern für die behandlung von bakteriellen meningitiden
RU2139092C1 (ru) * 1993-06-03 1999-10-10 Терапьютик Антибодиз Инк. Фрагменты антител в терапии
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
EP0732938A4 (fr) * 1993-12-01 1997-03-19 Unisearch Ltd Procede pour traiter des troubles intestinaux
GB2304342A (en) * 1995-08-18 1997-03-19 Univ Manchester Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
US20020025316A1 (en) 1995-08-18 2002-02-28 Ferguson Mark Williams James Pharmaceutical composition containing inhibitors of interferon-gamma
GB9517538D0 (en) * 1995-08-26 1995-10-25 Therapeutic Antibodies Inc Production and therapeutic combinations, of antibodies
ES2251248T3 (es) 1998-12-09 2006-04-16 Protein Design Labs, Inc. Uso de anticuerpos contra il-12 para tratar la psoriasis.
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
US20040062768A1 (en) * 2001-06-05 2004-04-01 Advanced Biotherapy, Inc. Compositions and methods for treating hyperimmune response in the eye
US20040086508A1 (en) * 2001-06-05 2004-05-06 Advanced Biotherapy, Inc. Treatment of organ transplant rejection
US6534059B2 (en) * 2001-06-05 2003-03-18 Advanced Biotherapy, Inc. Compositions and methods for treating hyperimmune response in the eye
EP1492818B1 (fr) * 2001-12-21 2012-08-08 CellAct Pharma GmbH Anticorps anti-tirc7 et antagonistes du tnf-alpha servant au traitement combine de maladies inflammatoires
UA76640C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
AU2003251238A1 (en) 2002-08-07 2004-02-25 Umc Utrecht Holding B.V. Modulation of platelet adhesion based on the surface exposed beta-switch loop of platelet glycoprotein ib-alpha
EP2258392A1 (fr) 2002-11-08 2010-12-08 Ablynx N.V. Procédé d'administration de polypeptides thérapeutiques
US9320792B2 (en) 2002-11-08 2016-04-26 Ablynx N.V. Pulmonary administration of immunoglobulin single variable domains and constructs thereof
US20060034845A1 (en) 2002-11-08 2006-02-16 Karen Silence Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
US9028816B2 (en) 2003-01-10 2015-05-12 Ablynx N.V. Polypeptides and polypeptide constructs comprising single domain antibodies directed against von Willebrand factor
PT1836500E (pt) 2005-01-14 2010-09-28 Ablynx Nv Métodos e ensaios para distinguir diferentes formas de doenças e perturbações caracterizadas por trombocitopenia e/ou por interacção espontânea entre o factor de von willebrand (vwf) e plaquetas
EP3243839A1 (fr) 2005-05-20 2017-11-15 Ablynx N.V. Nano-corps améliorés pour le traitement des troubles liés à l'agrégation
MXPA06003717A (es) * 2006-04-03 2006-09-29 Silanes Sa De Cv Lab Composiciones oftalmicas de proteinas inhibidoras de citocinas implicadas en procesos inflamatorios o inmunologicos.
WO2010077422A2 (fr) 2008-10-29 2010-07-08 Wyeth Llc Formulations de molécules de liaison d'antigène monodomaines
MX2011004558A (es) 2008-10-29 2011-06-01 Wyeth Llc Procedimientos para la purificacion de moleculas de union a antigeno de un unico dominio.
AU2011278032B2 (en) 2010-07-15 2015-07-23 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8700927A (nl) * 1987-04-16 1988-11-16 Stichting Rega V Z W Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing.
GB8805792D0 (en) * 1988-03-11 1988-04-13 Celltech Ltd Medicaments

Also Published As

Publication number Publication date
GB2247837B (en) 1992-10-28
JPH04505010A (ja) 1992-09-03
GB8905400D0 (en) 1989-04-19
GB9119037D0 (en) 1991-11-20
EP0387095A1 (fr) 1990-09-12
GB2247837A (en) 1992-03-18
CA2011893A1 (fr) 1990-09-09
KR920701466A (ko) 1992-08-11
AU5263490A (en) 1990-10-09
WO1990010707A1 (fr) 1990-09-20

Similar Documents

Publication Publication Date Title
GB2247837B (en) Pharmaceutical product for the treatment of immunoregulatory disorders
HU906006D0 (en) Process for the preparation of medical products
HUT64699A (en) Process for production of preparations for the treatment of disorders and disearses
HU896444D0 (en) Process for the preparation of pharmaceutical compositions
EP0569331A3 (en) Process for the preparation of addition products
ZA88754B (en) Substituted 3,4-dihydro-2h-benzopyrans,processes for their preparation,their use and pharmaceutical products based on these compounds
HU9101576D0 (en) Process for the production of medical preparations for decreasing heart-fibrillation
AU4530989A (en) Pharmaceutical composition for the treatment of cerebral edema
HU906129D0 (en) Process for the preparation of an age preventing product
ZA913844B (en) Therapeutic product
HU902047D0 (en) Process for the preparation of pharmaceutical product
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
GB9103278D0 (en) Drug for the treatment of dermatitis
EP0297296A3 (en) Process for the preparation of 2,2'-oxybisûn,n-dimethyl-ethylamine¨
HU904564D0 (en) Process for the preparation of solid medical products
IL93242A0 (en) Pharmaceutical preparation for the treatment of tonsillitis
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
HU905853D0 (en) Process for the preparation of medical products containing dopamine-autoreceptor-antagonists for treating drug dependence
EP0538729A3 (en) Process for the preparation of cycloalkanols
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
ZA925983B (en) Pharmaceutical compositions for the treatment of skin disorders
IE890515L (en) Pharmaceutical combination product
HU9200294D0 (en) Process for the production of medical preparations
KR0149275B1 (en) Medicaments for the treatment of cerebral apoplexy
ZA89125B (en) Product treatment